Jockey Club School of Public Health and Primary Care, Hong Kong; Stanley Ho Big Data Decision Analytics Research Centre, Hong Kong.
Stanley Ho Big Data Decision Analytics Research Centre, Hong Kong.
Clin Gastroenterol Hepatol. 2017 Jun;15(6):892-900.e4. doi: 10.1016/j.cgh.2016.09.155. Epub 2016 Oct 5.
BACKGROUND & AIMS: Population growth and changes in demographic structure are linked to trends in colorectal cancer (CRC) incidence. The aim of this study is to estimate future CRC incidence in the ageing population, and compare trends across developing and developed regions.
Cancer and population data were extracted from the International Agency for Research on Cancer. Annual incidence rates for the major types of cancer in 118 selected populations were extracted from 102 cancer registries in 39 countries worldwide. We selected 8 jurisdictions (from the United States, Europe, and Asia) that reported 20-year cancer incidence rates since 1988. Time series models were constructed to project cancer incidence, by sex and age, to 2030. Incidence rates for persons older than 65 years were combined and further adjusted for change of ageing population. We compared age-adjusted incidence rates among the jurisdictions.
The total population older than 65 years old was 12,917,794 in 1988, and the number increased by almost 40% to 17,950,115 in 2007. In developed countries in the West CRC incidence is predicted to decrease by 16.3% in the United States, increase by 4.8% in the United Kingdom, and increase by 4.7% in Sweden by 2030. In developing countries, such as China (Shanghai), Croatia, and Costa Rica, CRC incidence is predicted to increase in a steep curve by 2030 because of the growing population and ageing effect; in 2030, the incidence increases were 60.5% for China, 47.0% for Croatia, and 18.5% for Costa Rica. We also predict CRC incidence will increase greatly by 2030 in Japan and Hong Kong, which are developed regions.
With the exception of the United States, the incidence of CRC is expected to continue to rise in most regions in the coming decades, due to population growth and changes in demographic structure. The predicted increases are more marked in developing regions with limited health care resources.
人口增长和人口结构变化与结直肠癌(CRC)发病率的趋势有关。本研究旨在估算老龄化人口中未来 CRC 的发病率,并比较发展中和发达国家的趋势。
从国际癌症研究机构提取癌症和人口数据。从全球 39 个国家的 102 个癌症登记处提取了 118 个选定人群中主要癌症类型的年度发病率数据。我们选择了 8 个司法管辖区(来自美国、欧洲和亚洲),这些地区自 1988 年以来报告了 20 年的癌症发病率。构建时间序列模型,以预测 2030 年按性别和年龄划分的癌症发病率。将 65 岁以上人群的发病率合并,并进一步根据老龄化人口的变化进行调整。我们比较了司法管辖区之间的年龄调整发病率。
1988 年,65 岁以上的总人口为 12917794 人,到 2007 年,这一数字增加了近 40%,达到 17950115 人。在西方国家的发达国家,预计到 2030 年,美国 CRC 的发病率将下降 16.3%,英国将上升 4.8%,瑞典将上升 4.7%。在发展中国家,如中国(上海)、克罗地亚和哥斯达黎加,由于人口增长和老龄化的影响,CRC 的发病率预计将呈陡峭曲线上升;到 2030 年,中国的发病率将上升 60.5%,克罗地亚的发病率将上升 47.0%,哥斯达黎加的发病率将上升 18.5%。我们还预测,在日本和中国香港这两个发达地区,CRC 的发病率也将在未来几十年内大幅上升。
除美国外,未来几十年,大多数地区的 CRC 发病率预计将继续上升,这主要是由于人口增长和人口结构变化。在卫生保健资源有限的发展中地区,预计发病率增长更为显著。